Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 18504551)

1.

Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients.

Iapichino G, Albicini M, Umbrello M, Sacconi F, Fermo I, Pavlovich R, Paroni R, Bellani G, Mistraletti G, Cugno M, Pesenti A, Gattinoni L.

Intensive Care Med. 2008 Oct;34(10):1843-50. doi: 10.1007/s00134-008-1158-9. Epub 2008 May 27.

PMID:
18504551
2.

Glycemic control and insulin therapy in sepsis and critical illness.

Garcia Branco R, Tasker RC, Ramos Garcia PC, Piva JP, Dias Xavier L.

J Pediatr (Rio J). 2007 Nov;83(5 Suppl):S128-36. Review.

3.

Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.

Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C.

Crit Care Med. 2006 Dec;34(12):2974-8.

PMID:
17075371
4.

[Glycemic control in sepsis and septic shock: friend or foe?].

Ellger B, Westphal M, Stubbe HD, Van den Heuvel I, Van Aken H, Van den Berghe G.

Anaesthesist. 2008 Jan;57(1):43-8. Review. German.

PMID:
18034219
5.

Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate.

Freire AX, Avecillas JF, Yataco JC, Freire NE.

Crit Care Med. 2007 Apr;35(4):1222; author reply 1222. No abstract available.

PMID:
17413809
6.

Implementing strict glucose control: it is not that simple...

Beishuizen A, Groeneveld AB.

Crit Care Med. 2006 Dec;34(12):3050-1. No abstract available.

PMID:
17130704
7.

Tight glycemic control may favor fibrinolysis in patients with sepsis.

Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L.

Crit Care Med. 2009 Feb;37(2):424-31. doi: 10.1097/CCM.0b013e31819542da.

PMID:
19114908
8.

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G.

Crit Care Med. 2005 Mar;33(3):504-10.

PMID:
15753739
9.

Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery.

Biolo G, De Cicco M, Lorenzon S, Dal Mas V, Fantin D, Paroni R, Barazzoni R, Zanetti M, Iapichino G, Guarnieri G.

Crit Care Med. 2008 Jun;36(6):1768-75. doi: 10.1097/CCM.0b013e318174de32.

PMID:
18496366
10.

Intensive insulin therapy for acute hyperglycemia.

Read JL, Cheng EY.

AACN Adv Crit Care. 2007 Apr-Jun;18(2):200-12. Review.

PMID:
17473549
11.

Insulin therapy protects the central and peripheral nervous system of intensive care patients.

Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ.

Neurology. 2005 Apr 26;64(8):1348-53.

PMID:
15851721
12.

Higher body mass index predicts need for insulin but not hyperglycemia, nosocomial infection, or death in critically ill surgical patients.

Pieracci F, Hydo L, Eachempati S, Pomp A, Shou J, Barie PS.

Surg Infect (Larchmt). 2008 Apr;9(2):121-30. doi: 10.1089/sur.2007.039.

PMID:
18426344
13.

Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis.

Weiss SL, Haymond S, Ralay Ranaivo H, Wang D, De Jesus VR, Chace DH, Wainwright MS.

Pediatr Crit Care Med. 2012 Jul;13(4):e210-8. doi: 10.1097/PCC.0b013e318238b5cd.

14.

The glycemia threat in sepsis: too high, too low, or too... variable!

Spapen HD.

Crit Care Med. 2008 Aug;36(8):2459-60. doi: 10.1097/CCM.0b013e3181811260. No abstract available.

PMID:
18664802
15.

[Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis].

Yu WK, Li WQ, Wang XD, Yan XW, Qi XP, Li N, Li JS.

Zhonghua Wai Ke Za Zhi. 2005 Jan 1;43(1):29-32. Chinese.

PMID:
15774170
16.

Effects of hyperglycemia and insulin therapy on outcome in a hyperglycemic septic model of critical illness.

Heuer JG, Sharma GR, Zhang T, Ding C, Bailey DL, Stephens EJ, Holmes KC, Grubbs RL, Fynboe KA, Chen YF, Jakubowski JA.

J Trauma. 2006 Apr;60(4):865-72.

PMID:
16612310
17.

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes.

Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS.

Metabolism. 2002 Jul;51(7):843-6.

PMID:
12077728
18.
19.

[Hyperglycemia and intensive insulin therapy in sepsis].

Yao YM, Meng HD.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Feb;18(2):68-70. Chinese. No abstract available.

20.

Glucose metabolism and insulin resistance in sepsis.

Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G.

Curr Pharm Des. 2008;14(19):1887-99. Review.

PMID:
18691100
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk